Streptococcus pneumoniae serotype 19A in hospitalized children with invasive pneumococcal disease after the introduction of conjugated vaccines in Lima, Peru
Open Access
- 2 November 2023
- journal article
- research article
- Published by Elsevier in Journal of Infection and Public Health
- Vol. 17 (1) , 44-50
Abstract
No abstract availableKeywords
Funding Information
- Pfizer Global Pharmaceuticals
This publication has 25 references indexed in Scilit:
- Changes in empyema among U.S. children in the pneumococcal conjugate vaccine eraVaccine, 2016
- Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort studyThe Lancet Infectious Diseases, 2015
- Pneumococcal empyema and complicated pneumonias: global trends in incidence, prevalence, and serotype epidemiologyEuropean Journal of Clinical Microbiology & Infectious Diseases, 2014
- Impact of pneumococcal conjugate vaccines on nasopharyngeal carriage and invasive disease among unvaccinated people: Review of evidence on indirect effectsVaccine, 2013
- Early Trends for Invasive Pneumococcal Infections in Children After the Introduction of the 13-valent Pneumococcal Conjugate VaccineThe Pediatric Infectious Disease Journal, 2013
- Streptococcus pneumoniae serotype 19A in Latin America and the Caribbean: a systematic review and meta-analysis, 1990–2010BMC Infectious Diseases, 2012
- Serotype replacement in disease after pneumococcal vaccinationThe Lancet, 2011
- Invasive pneumococcal diseases among hospitalized children in Lima, PeruRevista Panamericana de Salud Pública, 2010
- Serotype 19A Is the Most Common Serotype Causing Invasive Pneumococcal Infections in ChildrenPediatrics, 2010
- Sequential Multiplex PCR Approach for Determining Capsular Serotypes of Streptococcus pneumoniae IsolatesJournal of Clinical Microbiology, 2006